Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/11526
Type
ArticleCopyright
Restricted access
Collections
- INI - Artigos de Periódicos [3646]
- IOC - Artigos de Periódicos [12969]
Metadata
Show full item record
INSTITUTIONAL PREVENTION POLICIES AND RATES OF GROUP B STREPTOCOCCUS INFECTION AMONG HIV-INFECTED PREGNANT WOMEN AND THEIR INFANTS IN LATIN AMERICA
Author
Affilliation
Hospital Federal dos Servidores do Estado do Rio de Janeiro. Rio de Janeiro, RJ, Brasil.
Hospital Federal dos Servidores do Estado Rio de Janeiro. Serviço de Doenças Infecciosas e Parasitárias. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas - IPEC. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas - IPEC. Rio de Janeiro, RJ, Brasil.
Westat. Rockville, USA.
Westat. Rockville, USA.
National Institutes of Health. Department of Health and Human Services. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Pediatric, Adolescent, and Maternal AIDS Branch. Bethesda, USA / Department of Health and Human Services. Office of the Assistant Secretary of Health/Office of the Secretary. National Vaccine Program Office. Washington, DC, USA.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil.
Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Hospital das Clínicas. Departamento de Ginecologia e Obstetrícia. Ribeirão Preto, SP, Brasil.
Hospital General de Agudos Jose Maria Ramos Mejia. Buenos Aires, Argentina
Universidade de São Paulo. Escola Paulista de Medicina. São Paulo, SP, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil. / Hospital Geral de Nova Iguaçu. Nova Iguaçu, RJ, Brasil.
Hospital Federal dos Servidores do Estado Rio de Janeiro. Serviço de Doenças Infecciosas e Parasitárias. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas - IPEC. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto de Pesquisa Clínica Evandro Chagas - IPEC. Rio de Janeiro, RJ, Brasil.
Westat. Rockville, USA.
Westat. Rockville, USA.
National Institutes of Health. Department of Health and Human Services. Eunice Kennedy Shriver National Institute of Child Health and Human Development. Pediatric, Adolescent, and Maternal AIDS Branch. Bethesda, USA / Department of Health and Human Services. Office of the Assistant Secretary of Health/Office of the Secretary. National Vaccine Program Office. Washington, DC, USA.
Universidade Federal de Minas Gerais. Faculdade de Medicina. Belo Horizonte, MG, Brasil.
Universidade de São Paulo. Faculdade de Medicina de Ribeirão Preto. Hospital das Clínicas. Departamento de Ginecologia e Obstetrícia. Ribeirão Preto, SP, Brasil.
Hospital General de Agudos Jose Maria Ramos Mejia. Buenos Aires, Argentina
Universidade de São Paulo. Escola Paulista de Medicina. São Paulo, SP, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ, Brasil. / Hospital Geral de Nova Iguaçu. Nova Iguaçu, RJ, Brasil.
Abstract
Objective: To describe Group B Streptococcus (GBS) prevention policies at 12 Latin American sites participating
in the NICHD (Eunice Kennedy Shriver National Institute of Child Health and Human Development)
International Site Development Initiative (NISDI) Longitudinal Study in Latin American Countries (LILAC)
and to determine rates of rectovaginal colonization and GBS-related disease among HIV-infected pregnant
women and their infants. Methods: Site surveys were used to assess prevention policies and practices administered
cross-sectionally during 2010. Data collected in NISDI from 2008 to 2010 regarding HIV-infected pregnant
women were used to determine rates of colonization and GBS-related disease. Results: Of the 9 sites
with a GBS prevention policy, 7 performed routine rectovaginal screening for GBS. Of the 401 women included
in the NISDI study, 56.9% were at sites that screened. The GBS colonization rate was 8.3% (19/228 women;
95% confidence interval [CI], 5.1%–12.7%). Disease related to GBS occurred in 0.5% of the participants (2/401
women; 95% CI, 0.1%–1.8%); however, no GBS-related disease was reported among the 398 infants (95% CI,
0.0%–0.9%). Conclusion: Improved efforts to implement prevention policies and continued surveillance for
GBS are needed to understand the impact of GBS among HIV-infected pregnant women and their infants in
Latin America.
Share